The Neurontin Controversy: Unveiling Big Pharma's Off-Label Marketing Practices
22 Mar, 2024In 1996, Dr. David Franklin blew the whistle on Parke-Davis for illegal promotion of Neurontin for unapproved uses. This led to a landmark lawsuit under the False Claims Act, resulting in a $430 million settlement, and raised critical questions about pharmaceutical marketing ethics.
READ MORE